Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchiseptica.

[1]  Huanchun Chen,et al.  Subcutaneous Vaccination with Attenuated Salmonella enterica Serovar Choleraesuis C500 Expressing Recombinant Filamentous Hemagglutinin and Pertactin Antigens Protects Mice against Fatal Infections with both S. enterica Serovar Choleraesuis and Bordetella bronchiseptica , 2008, Infection and Immunity.

[2]  T. Nicholson,et al.  Coinfection of pigs with porcine respiratory coronavirus and Bordetella bronchiseptica , 2007, Veterinary Microbiology.

[3]  D. Wolfe,et al.  Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. , 2007, Microbes and infection.

[4]  S. Halperin,et al.  Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis , 2006, Clinical and experimental immunology.

[5]  Huanchun Chen,et al.  Generation of monoclonal antibodies and epitope mapping of ApxIVA of Actinobacillus pleuropneumoniae. , 2006, Molecular immunology.

[6]  F. Mooi,et al.  Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica , 2005, PLoS pathogens.

[7]  Seema Mattoo,et al.  Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.

[8]  K. Register.  Comparative sequence analysis of Bordetella bronchiseptica pertactin gene (prn) repeat region variants in swine vaccines and field isolates. , 2004, Vaccine.

[9]  S. Brockmeier.  Prior infection with Bordetella bronchiseptica increases nasal colonization by Haemophilus parasuis in swine. , 2004, Veterinary microbiology.

[10]  M. Roberts,et al.  Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. , 2003, FEMS immunology and medical microbiology.

[11]  F. Mooi,et al.  Role of Antibodies against Bordetella pertussis Virulence Factors in Adherence of Bordetella pertussis and Bordetella parapertussis to Human Bronchial Epithelial cells , 1999, Infection and Immunity.

[12]  L. Backstrom.  Present uses of and experiences with swine vaccines. , 1999 .

[13]  B. Finlay,et al.  Antigenic Analysis of Bordetella pertussis Filamentous Hemagglutinin with Phage Display Libraries and Rabbit Anti-Filamentous Hemagglutinin Polyclonal Antibodies , 1998, Infection and Immunity.

[14]  C. Locht,et al.  Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. , 1997, The Journal of infectious diseases.

[15]  H. Hallander,et al.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.

[16]  J. Poolman,et al.  The purification and protective capacity of Bordetella pertussis outer membrane proteins. , 1995, Vaccine.

[17]  C. Locht,et al.  Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis , 1994, Infection and immunity.

[18]  M. Brennan,et al.  Inhibition of Bordetella pertussis filamentous hemagglutinin-mediated cell adherence with monoclonal antibodies. , 1993, FEMS microbiology letters.

[19]  R. Rappuoli,et al.  Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses , 1991, Infection and immunity.

[20]  T. Okabe,et al.  Characterization of haemagglutinin from Bordetella bronchiseptica. , 1991, Vaccine.

[21]  I. Charles,et al.  Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis , 1991, European journal of immunology.

[22]  P. Novotný,et al.  Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets , 1990, Infection and immunity.

[23]  A. Chubb,et al.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay , 1985, Infection and immunity.

[24]  J. Iványi,et al.  Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica , 1985, Infection and immunity.

[25]  E. Hewlett,et al.  Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells , 1984, Journal of clinical microbiology.

[26]  R. Goodnow.  Biology of Bordetella bronchiseptica , 1980, Microbiological reviews.